{"DataElement":{"publicId":"2195292","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Laryngeal Nerves Function Grade","preferredDefinition":"in CTC category Neurology, assessment of the severity of a laryngeal nerve dysfunction adverse event using a graded scale.","longName":"CTC_AE_LANRV_FUNC_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195290","version":"2","preferredName":"Common Toxicity Criteria Adverse Event Laryngeal Nerves Function","preferredDefinition":"information related to the CTC adverse event of laryngeal nerve dysfunction.","longName":"CTC_AE_LARYNNRV_FUNC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660701","version":"1","preferredName":"Laryngeal Nerves Function","preferredDefinition":"MSH2005_2004_10_12:Function; what something is used for.","longName":"C0023056:C25518","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laryngeal Nerves","conceptCode":"C0023056","definition":"MSH2005_2004_10_12","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Function","conceptCode":"C25518","definition":"The normal action performed by a structure or device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-CA26-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2045A13-8704-ADB5-E040-BB89AD4374D9","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2195291","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Laryngeal Nerve Function Grade","preferredDefinition":"in CTC category Neurology, assessment of the severity of a laryngeal nerve dysfunction adverse event using a graded scale.","longName":"CTC_AE_LANRV_FUNC_GD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED19D221-019E-1D77-E034-0003BA3F9857","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"1","valueDescription":"Asymptomatic, weakness on clinical examination/testing only","ValueMeaning":{"publicId":"2572763","version":"1","preferredName":"Asymptomatic, weakness on clinical examination/testing only","longName":"2572763","preferredDefinition":"Asymptomatic, weakness on clinical examination/testing only","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E948-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED19D221-01A1-1D77-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"Symptomatic, but not interfering with ADL; intervention not indicated","ValueMeaning":{"publicId":"2572764","version":"1","preferredName":"Symptomatic, but not interfering with ADL; intervention not indicated","longName":"2572764","preferredDefinition":"Symptomatic, but not interfering with ADL; intervention not indicated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E949-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED19D221-01A5-1D77-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"Symptomatic, interfering with ADL; intervention indicated (e.g., thyroplasty, vocal cord injection)","ValueMeaning":{"publicId":"2572765","version":"1","preferredName":"Symptomatic, interfering with ADL; intervention indicated (e.g., thyroplasty, vocal cord injection)","longName":"2572765","preferredDefinition":"Symptomatic, interfering with ADL; intervention indicated (e.g., thyroplasty, vocal cord injection)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E94A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED19D221-01A9-1D77-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"Life-threatening; tracheostomy indicated","ValueMeaning":{"publicId":"2572766","version":"1","preferredName":"Life-threatening; tracheostomy indicated","longName":"2572766","preferredDefinition":"Life-threatening; tracheostomy indicated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E94B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SHIDED","dateModified":"2005-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED19D221-01AD-1D77-E034-0003BA3F9857","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"5","valueDescription":"Death","ValueMeaning":{"publicId":"2567604","version":"1","preferredName":"Death","longName":"2567604","preferredDefinition":"The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D521-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"COOPERM","dateModified":"2015-11-24","changeDescription":"Added the NCIt concept definition as the System Generated definition per request by NMDP. mc 11/24/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED1B0B99-AD3E-1F39-E034-0003BA3F9857","beginDate":"2002-10-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED19D221-0173-1D77-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812032","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000132","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CTC Adverse Event Laryngeal n","type":"Preferred Question Text","description":"CTC Adverse Event Laryngeal nerve dysfunction Grade","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Laryngeal nerve dysfunction Grade","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)","url":"http://ctep.cancer.gov/reporting/ctc.html","context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ED19D221-018A-1D77-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"ALAIS","dateModified":"2011-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}